Back to search

Article

Association between plasma phospho-tau181 and cognitive change from age 73 to 82: Lothian Birth Cohort 1936

2021-11-25

Abstract excerpt

<h4>INTRODUCTION</h4> Plasma phospho-tau 181 (p-tau181) is a promising blood biomarker for Alzheimer’s disease. However, its predictive validity for age-related cognitive decline without dementia remains unclear. Several forms of p-tau have been shown to contribute to synapse degeneration, but it is unknown whether p-tau181 is present in synapses. Here, we tested whether plasma p-tau181predicts cognitive decline...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e883d604-8e71-5a1a-9244-4ef18c0d62f5
DOI
10.1101/2021.11.24.469836
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association between plasma phospho-tau181 and cognitive change from age 73 to 82: Lothian Birth Cohort 1936DOI 10.1101/2021.11.24.469836
Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognitionSemantic proximity
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort studySemantic proximity
Association of plasma phosphor-tau181 with Aβ levels may vary by APOE ε4 status and sex among non-demented old adults.Semantic proximity
Examining the relationship between plasma pTau181 and cognitive decline, structural brain integrity, and biological ageing in midlifeSemantic proximity
CNS-selective plasma p-tau217 accurately captures Alzheimer’s disease pathology and progressionSemantic proximity
APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.Semantic proximity
Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease StagesSemantic proximity
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresSemantic proximity
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based studySemantic proximity
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.Semantic proximity
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.Semantic proximity
A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker TestsSemantic proximity
Select a neighboring publication to make it the new centre.